Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8 USD | -1,78% | -5,88% | -10,01% |
05/04 | ACHILLES THERAPEUTICS PLC : Chardan Research herhaalt koopadvies | ZM |
05/04 | ACHILLES THERAPEUTICS PLC : Piper Sandler verlaagt advies naar Neutraal | ZM |
Vakgebied
Aantal werknemers: 210
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sergio Quezada
FOU | Founder | 49 | 01-11-20 |
Karl Peggs
FOU | Founder | 57 | 01-11-20 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01-01-18 |
Robert Coutts
DFI | Director of Finance/CFO | 40 | 01-11-20 |
Edward Samuel
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-22 |
Shree Patel
COO | Chief Operating Officer | - | - |
James Taylor
PRN | Corporate Officer/Principal | - | 01-07-22 |
Tariq Ahmed
HRO | Human Resources Officer | - | 01-03-20 |
Daniel Hood
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Carsten Boess
BRD | Director/Board Member | 57 | 01-04-20 |
Edwin Moses
CHM | Chairman | 69 | - |
Director/Board Member | 69 | 04-05-22 | |
Michael Giordano
BRD | Director/Board Member | 66 | 01-09-18 |
Julie O'Neill
BRD | Director/Board Member | 58 | 03-05-21 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 082 948 | 38 437 984 ( 93,56 %) | 0 | 93,56 % |
Bedrijfsgegevens
Achilles Therapeutics Plc
245 Hammersmith Road
W6 8PW, London
+44 20 8154 4600
http://www.achillestx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,01% | 33,46 mln. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |
- Beurs
- Aandelen
- Koers ACHL
- Onderneming Achilles Therapeutics plc